O'Keeffe Charles B has filed 22 insider transactions across 1 company since January 2023.
Most recent transaction: a option exercise of 4000 shares of CATALYST PHARMACEUTICALS, INC. ($CPRX) on February 14, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 14, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | O'Keeffe Charles B | Director | M | Common Stock, par value $0.001 per share | 4000 | $0.00 | 732,470.0000 | 124,943,603 | 0.55% | 0.00% |
| Feb. 14, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | O'Keeffe Charles B | Director | M | Restricted Stock Units | 4000 | $0.00 | 208,274.0000 | 124,943,603 | 1.88% | 0.00% |
| Dec. 27, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | O'Keeffe Charles B | Director | M | Common Stock, par value $0.001 per share | 1333 | $0.00 | 728,470.0000 | 125,407,279 | 0.18% | 0.00% |
| Dec. 27, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | O'Keeffe Charles B | Director | M | Restricted Stock Units | 1333 | $0.00 | 212,274.0000 | 125,407,279 | 0.62% | 0.00% |
| Dec. 9, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | O'Keeffe Charles B | Director | M | Common Stock, par value $0.001 per share | 1413 | $0.00 | 687,137.0000 | 125,407,279 | 0.21% | 0.00% |
| Dec. 10, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | O'Keeffe Charles B | Director | M | Common Stock, par value $0.001 per share | 40000 | $4.01 | 727,137.0000 | 125,407,279 | 5.82% | 0.03% |
| Dec. 9, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | O'Keeffe Charles B | Director | M | Restricted Stock Units | 1413 | $0.00 | 253,607.0000 | 125,407,279 | 0.55% | 0.00% |
| Dec. 10, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | O'Keeffe Charles B | Director | M | Options to purchase common stock | 40000 | $0.00 | 213,607.0000 | 125,407,279 | 15.77% | 0.03% |
| Nov. 21, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | O'Keeffe Charles B | Director | A | Options to purchase common stock | 23248 | $0.00 | 252,179.0000 | 125,407,279 | 10.16% | 0.02% |
| Nov. 21, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | O'Keeffe Charles B | Director | A | Restricted stock units | 2841 | $0.00 | 255,020.0000 | 125,407,279 | 1.13% | 0.00% |
| Feb. 15, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | O'Keeffe Charles B | Director | M | Common Stock, par value $0.001 per share | 4000 | $0.00 | 685,724.0000 | 113,753,154 | 0.59% | 0.00% |
| Feb. 15, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | O'Keeffe Charles B | Director | M | Restricted Stock Units | 4000 | $0.00 | 228,931.0000 | 113,753,154 | 1.72% | 0.00% |
| Jan. 2, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | O'Keeffe Charles B | Director | M | Common Stock, par value $0.001 per share | 60000 | $1.13 | 681,724.0000 | 113,753,154 | 9.65% | 0.05% |
| Jan. 2, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | O'Keeffe Charles B | Director | M | Options to purchase common stock | 60000 | $0.00 | 232,931.0000 | 113,753,154 | 20.48% | 0.05% |
| Dec. 27, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | O'Keeffe Charles B | Director | M | Common Stock, par value $0.001 per share | 1333 | $0.00 | 621,724.0000 | 111,375,631 | 0.21% | 0.00% |
| Dec. 27, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | O'Keeffe Charles B | Director | M | Restricted Stock Units | 1333 | $0.00 | 292,931.0000 | 111,375,631 | 0.45% | 0.00% |
| Dec. 8, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | O'Keeffe Charles B | Director | A | Options to purchase common stock | 29524 | $0.00 | 290,024.0000 | 111,375,631 | 11.33% | 0.03% |
| Dec. 8, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | O'Keeffe Charles B | Director | A | Restricted stock units | 4240 | $0.00 | 294,264.0000 | 111,375,631 | 1.46% | 0.00% |
| Feb. 15, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | O'Keeffe Charles B | Director | M | Common Stock, par value $0.001 per share | 4000 | $0.00 | 620,391.0000 | 111,375,631 | 0.65% | 0.00% |
| Feb. 15, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | O'Keeffe Charles B | Director | M | Restricted Stock Units | 4000 | $0.00 | 260,500.0000 | 111,375,631 | 1.51% | 0.00% |
| Jan. 24, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | O'Keeffe Charles B | Director | M | Common stock, par value $0.001 per share | 50000 | $0.79 | 616,391.0000 | 111,375,631 | 8.83% | 0.04% |
| Jan. 24, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | O'Keeffe Charles B | Director | M | Options to purchase common stock | 50000 | $0.00 | 264,500.0000 | 111,375,631 | 15.90% | 0.04% |